1Emorine LJ, Marullo S, Briend - Sutren M, et al. Molecular characterization of the human β3 - adrenergic receptor. Science1989, 245:1118.
2Insel PA. Adrenergic receptors - evolving concepts and clinical implication. N Engl J Med 1996, 334:580.
3Strosberg AD. Structure and function of the Beta 3 adrenergic reeceptor. Annu Rev Pharmacol Toical 1997, 37:421.
4Walston J, Silver K, Bogardus C, et al. Time of onset of non - insulin - dependent diabetes mellitus and genetic variation in the β3 - adrenergic - receptor gene. N Engl J med 1995, 333:343.
5Cle ment K, Vaisse C, Manning BJ et al. Genetic Variation in the β3 - adrenergic - receptor and an increased capactity to gain weight in patients with morbid obesity. N Engl J Med 1995,333 : 352.
8Weyer C,Tataranni PA,Snitker S,et al.Increase in insulin action and fat oxidation after treatment With CL316243, a highly selective β3 - adrenoceptor agonist in humans. Diabetes1998, 47:1555.
二级参考文献7
1Yuan X，Diabetes Res Clin Pract，1997年，37卷，1页
2Silver K，J Clin Endocrinol Metab，1996年，81卷，4155页
31.Urhammer S，Clausen J，Hansen T，et al.Insulin sensitivity and bodyweight changes in young white carrieries of the condon 64 amino acid polymorphism of theβ3－adrenergic receptor gene.Diabetes，1996，45：1115.
42.Walton J，Silver K，Bogardus C，et al.Time of onset of non-insulin-dependent diabetesmellitus and genetic variation in the β3-adrenergic-receptor gene.N Engl J Med，1995，333：343.
53.Clément K，VaisseC，Minning BJ，et al.Genetic variation in the β3-adrenergic-receptor and anincreased capacity to gain weight in patients with morbid obesity.N Engl J Med，1995，333：352.
64.Fu jisawa T，Ikegamic H，Yoshida T，et al.Association of Trp64Arg mutation of the β3-adrenergic-receptorwith NIDDM and body weight gain.Diabetelogia，1996，39：349.
